Dianeal + Physioneal + Extraneal + Nutrineal

Phase 3Completed
0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
4
Phase 3
5
Approved
Indication / Disease

ESRD

Conditions

ESRD, Diabetes

Trial Timeline

Apr 1, 2008 → Jul 1, 2011

About Dianeal + Physioneal + Extraneal + Nutrineal

Dianeal + Physioneal + Extraneal + Nutrineal is a phase 3 stage product being developed by Baxter for ESRD. The current trial status is completed. This product is registered under clinical trial identifier NCT00567398. Target conditions include ESRD, Diabetes.

What happened to similar drugs?

4 of 7 similar drugs in ESRD were approved

Approved (4) Terminated (0) Active (3)

Hype Score Breakdown

Clinical
17
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00567398Phase 3Completed

Competing Products

17 competing products in ESRD

See all competitors
ProductCompanyStageHype Score
RoxadustatAstraZenecaPhase 3
40
DoravirineMerckApproved
43
MK-2060 + PlaceboMerckPhase 1
29
Induction therapy + Corticosteroids + EVR+rCNI + MPA+sCNINovartisApproved
43
Mycophenolic Acid (Myfortic)NovartisApproved
43
AvacopanAmgenPhase 1
29
[¹⁴C]EtelcalcetideAmgenPhase 1
29
apixabanBristol Myers SquibbPhase 2
35
ISIS 416858 + PlaceboBayerPhase 2
32
ISIS 416858 + PlaceboBayerPhase 2
32
10 GE XenokidneyUnited TherapeuticsPhase 1/2
36
GGTA1 KO ThymokidneyUnited TherapeuticsPhase 1/2
36
Physioneal + Dianeal + Extraneal + NutrinealBaxterApproved
40
Dianeal + Dianeal, Extraneal, NutrinealBaxterPhase 3
37
Acellular Tissue Engineered Vessel (ATEV)HumacytePhase 3
37
Soluble Ferric Pyrophosphate + Soluble Ferric Pyrophosphate + Soluble Ferric Pyrophosphate + Soluble Ferric PyrophosphateRockwell MedicalPhase 2
25
soluble ferric pyrophosphate (SFP)Rockwell MedicalPre-clinical
8